LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 285

Search options

  1. Article: Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.

    Ignarro, Louis J

    Cardiovascular therapeutics

    2008  Volume 26, Issue 2, Page(s) 115–134

    Abstract: Nebivolol is a racemic combination of d-nebivolol (+SRRR nebivolol) and l-nebivolol (-RSSS ... developing from a central nitrogen atom. D-nebivolol and l-nebivolol divaricate pharmacologically and ... of the l-enantiomer, which in itself does not influence systolic and diastolic blood pressure. Furthermore ...

    Abstract Nebivolol is a racemic combination of d-nebivolol (+SRRR nebivolol) and l-nebivolol (-RSSS nebivolol) that differs chemically from other beta-blockers, with an absolutely symmetrical configuration developing from a central nitrogen atom. D-nebivolol and l-nebivolol divaricate pharmacologically and therapeutically, with a noticeably different profile from that of conventional beta-blockers; for instance, the selective blocking of beta(1)-adrenoceptors is determined almost exclusively by d-nebivolol. Both enantiomers act synergistically with respect to blood pressure reduction: the effect of nebivolol on heart rate is exclusively exerted by d-nebivolol, with these hypotensive effects enhanced by the addition of the l-enantiomer, which in itself does not influence systolic and diastolic blood pressure. Furthermore, this pronounced and lasting blood pressure reduction is roughly equal to the effect of conventional beta-blockers in high doses. In certain vascular districts, nebivolol stimulates endothelial nitric oxide (NO) synthesis, thereby increasing the availability of NO in the endothelium, smooth muscle, and platelets and, consequently, producing a sustained vasodilation, with decreases in peripheral resistance and blood pressure. These effects are not shared by other beta-adrenoceptor blockers used as references and mainly rely on the l-enantiomer. L-nebivolol also increases NO availability under conditions of oxidative stress by the inhibition of endothelial NO synthase (eNOS) uncoupling, thereby reducing NO inactivation. Furthermore, neither nebivolol nor its enantiomers show any intrinsic sympathomimetic activity and undesirable beta-blocker effects, such as a decrease in cardiac output, which do not occur or are less pronounced with the combination of d-nebivolol and l-nebivolol. In conclusion, the independent pharmacologic and clinical effects of d-nebivolol and l-nebivolol act synergistically to produce a cardiovascular profile that differs noticeably from that of conventional beta-blockers.
    MeSH term(s) Adrenergic beta-1 Receptor Antagonists ; Adrenergic beta-Antagonists/pharmacology ; Animals ; Benzopyrans/pharmacology ; Blood Platelets/drug effects ; Blood Platelets/metabolism ; Blood Pressure/drug effects ; Dose-Response Relationship, Drug ; Endothelium, Vascular/drug effects ; Endothelium, Vascular/metabolism ; Ethanolamines/pharmacology ; Heart Rate/drug effects ; Hemodynamics/drug effects ; Humans ; Isomerism ; Molecular Structure ; Myocardial Contraction/drug effects ; Nebivolol ; Nitric Oxide/metabolism ; Structure-Activity Relationship ; Up-Regulation ; Vasodilation/drug effects
    Chemical Substances Adrenergic beta-1 Receptor Antagonists ; Adrenergic beta-Antagonists ; Benzopyrans ; Ethanolamines ; Nebivolol (030Y90569U) ; Nitric Oxide (31C4KY9ESH)
    Language English
    Publishing date 2008
    Publishing country England
    Document type Journal Article
    ZDB-ID 2428378-2
    ISSN 1755-5922 ; 1755-5914
    ISSN (online) 1755-5922
    ISSN 1755-5914
    DOI 10.1111/j.1527-3466.2008.00044.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.

    Ignarro, L J

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

    2002  Volume 53, Issue 4 Pt 1, Page(s) 503–514

    Abstract: In retrospect, basic research in the fields of NO and cyclic GMP during the past two decades appears to have followed a logical course beginning with the findings that NO and cyclic GMP are vascular smooth muscle relaxants, that nitroglycerin relaxes ... ...

    Abstract In retrospect, basic research in the fields of NO and cyclic GMP during the past two decades appears to have followed a logical course beginning with the findings that NO and cyclic GMP are vascular smooth muscle relaxants, that nitroglycerin relaxes smooth muscle by metabolism to NO, progressing to the discovery that mammalian cells synthesize NO, and finally the revelation that NO is a neurotransmitter mediating vasodilation in specialized vascular beds. A great deal of basic and clinical research on the physiological and pathophysiological roles of NO in cardiovascular function has been conducted since the discovery that EDRF is NO. The new knowledge on NO should enable investigators in this field to develop novel and more effective therapeutic strategies for the prevention, diagnosis and treatment of numerous cardiovascular disorders. Since NO elicits a protective and beneficial action in many disease states, novel NO donor drugs for clinical use should prove to be very effective drugs for the treatment of essential hypertension, stroke, coronary artery disease, vascular complications of diabetes, impotency and other disorders involving the vascular system.
    MeSH term(s) Animals ; Blood Vessels/physiology ; Humans ; Muscle, Smooth, Vascular/physiology ; Nitric Oxide/physiology ; Nitroglycerin/metabolism ; Penile Erection/physiology ; Signal Transduction/physiology ; Vasomotor System/physiology
    Chemical Substances Nitric Oxide (31C4KY9ESH) ; Nitroglycerin (G59M7S0WS3)
    Language English
    Publishing date 2002-12
    Publishing country Poland
    Document type Journal Article ; Review
    ZDB-ID 1125221-2
    ISSN 1899-1505 ; 0867-5910 ; 0044-6033
    ISSN (online) 1899-1505
    ISSN 0867-5910 ; 0044-6033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The unique role of nitric oxide as a signaling molecule in the cardiovascular system.

    Ignarro, L J

    Italian heart journal : official journal of the Italian Federation of Cardiology

    2000  Volume 1 Suppl 3, Page(s) S28–9

    MeSH term(s) Cardiovascular System/metabolism ; Cell Communication ; Humans ; Nitric Oxide/metabolism
    Chemical Substances Nitric Oxide (31C4KY9ESH)
    Language English
    Publishing date 2000-09
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2012387-5
    ISSN 1972-6465 ; 1129-471X ; 1129-4728
    ISSN (online) 1972-6465
    ISSN 1129-471X ; 1129-4728
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Nitric oxide: a unique endogenous signaling molecule in vascular biology.

    Ignarro, L J

    Bioscience reports

    1999  Volume 19, Issue 2, Page(s) 51–71

    Abstract: The properties of nitric oxide as an endogenous cell signaling molecule in vascular biology are described. ...

    Abstract The properties of nitric oxide as an endogenous cell signaling molecule in vascular biology are described.
    MeSH term(s) Animals ; Blood Vessels/physiology ; Endothelium, Vascular/physiology ; Forecasting ; Guanylate Cyclase/metabolism ; Humans ; Nitric Oxide/pharmacology ; Nitric Oxide/physiology ; Nitroglycerin/metabolism ; Nobel Prize ; Platelet Aggregation Inhibitors/metabolism ; Platelet Aggregation Inhibitors/pharmacology ; Signal Transduction ; Vasodilator Agents/metabolism
    Chemical Substances Platelet Aggregation Inhibitors ; Vasodilator Agents ; Nitric Oxide (31C4KY9ESH) ; Guanylate Cyclase (EC 4.6.1.2) ; Nitroglycerin (G59M7S0WS3)
    Language English
    Publishing date 1999-04-19
    Publishing country England
    Document type Journal Article ; Lecture ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 764946-0
    ISSN 1573-4935 ; 0144-8463
    ISSN (online) 1573-4935
    ISSN 0144-8463
    DOI 10.1023/a:1020150124721
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Physiology and pathophysiology of nitric oxide.

    Ignarro, L J

    Kidney international. Supplement

    1996  Volume 55, Page(s) S2–5

    Abstract: ... in 1980. Subsequent studies revealed that EDRF is NO, and is synthesized by mammalian cells from L ... catalyzes the NADPH- and oxygen-dependent oxygenation of L-arginine to NO plus L-citrulline in a reaction ...

    Abstract Nitric oxide (NO) was discovered to be a potent vasodilator, inhibitor of platelet aggregation, and active species of nitroglycerin before the discovery of endothelium-derived relaxing factor (EDRF) in 1980. Subsequent studies revealed that EDRF is NO, and is synthesized by mammalian cells from L-arginine through a complex oxidation reaction catalyzed by the flavo-hemoprotein NO synthase (NOS). NOS catalyzes the NADPH- and oxygen-dependent oxygenation of L-arginine to NO plus L-citrulline in a reaction that requires at least six cofactors including NADPH, FAD, FMN, tetrahydrobiopterin, heme, and calmodulin. NO elicits its known physiological actions by activating cytosolic guanylate cyclase, which converts GTP to cyclic GMP. Endothelial NOS and neuronal NOS are constitutively present and activated by increases in intracellular calcium triggered by endogenous chemicals. NO then diffuses into nearby target cells to elevate cyclic GMP levels and thereby trigger cell function. NOS activity can also be regulated by a negative feedback mechanism involving NO itself. Much greater quantities of NO are produced pathophysiologically by a distinct form of NOS that can be induced in vascular endothelium, smooth muscle and macrophages by endotoxin and cytokines. This high-output production of NO is not regulated by calcium and is cytotoxic by mechanisms involving interaction with iron-containing proteins.
    MeSH term(s) Animals ; Humans ; Hypertension/physiopathology ; Nitric Oxide/physiology
    Chemical Substances Nitric Oxide (31C4KY9ESH)
    Language English
    Publishing date 1996-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 193442-9
    ISSN 2157-1716 ; 0098-6577 ; 2157-1724
    ISSN (online) 2157-1716
    ISSN 0098-6577 ; 2157-1724
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Comment on "Evidence that the ProPerDP method is inadequate for protein persulfidation detection due to lack of specificity".

    Dóka, Éva / Arnér, Elias S J / Schmidt, Edward E / Dick, Tobias P / van der Vliet, Albert / Yang, Jing / Szatmári, Réka / Ditrói, Tamás / Wallace, John L / Cirino, Giuseppe / Olson, Kenneth / Motohashi, Hozumi / Fukuto, Jon M / Pluth, Michael D / Feelisch, Martin / Akaike, Takaaki / Wink, David A / Ignarro, Louis J / Nagy, Péter

    Science advances

    2021  Volume 7, Issue 17

    Abstract: The recent report by ... ...

    Abstract The recent report by Fan
    Language English
    Publishing date 2021-04-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.abe7006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Erectile hydraulics: maximizing inflow while minimizing outflow.

    Meldrum, David R / Burnett, Arthur L / Dorey, Grace / Esposito, Katherine / Ignarro, Louis J

    The journal of sexual medicine

    2014  Volume 11, Issue 5, Page(s) 1208–1220

    Abstract: Introduction: Penile rigidity depends on maximizing inflow while minimizing outflow.: Aim: The aim of this review is to describe the principal factors and mechanisms involved.: Main outcome measure: Erectile quality is the main outcome measure.: ...

    Abstract Introduction: Penile rigidity depends on maximizing inflow while minimizing outflow.
    Aim: The aim of this review is to describe the principal factors and mechanisms involved.
    Main outcome measure: Erectile quality is the main outcome measure.
    Methods: Data from the pertinent literature were examined to inform our conclusions.
    Results: Nitric oxide (NO) is the principal factor increasing blood flow into the penis. Penile engorgement and the pelvic floor muscles maintain an adequate erection by impeding outflow of blood by exerting pressure on the penile veins from within and from outside of the penile tunica. Extrinsic pressure by the pelvic floor muscles further raises intracavernosal pressure above maximum inflow pressure to achieve full penile rigidity. Aging and poor lifestyle choices are associated with metabolic impediments to NO production. Aging is also associated with fewer smooth muscle cells and increased fibrosis within the corpora cavernosa, preventing adequate penile engorgement and pressure on the penile veins. Those same penile structural changes occur rapidly following the penile nerve injury that accompanies even "nerve-sparing" radical prostatectomy and are largely prevented in animal models by early chronic use of a phosphodiesterase type 5 (PDE5) inhibitor. Pelvic floor muscles may also decrease in tone and bulk with age, and pelvic floor muscle exercises have been shown to improve erectile function to a similar degree compared with a PDE5 inhibitor in men with erectile dysfunction (ED).
    Conclusions: Because NO is critical for vascular health and ED is strongly associated with cardiovascular disease, maximal attention should be focused on measures known to increase vascular NO production, including the use of PDE5 inhibitors. Attention should also be paid to early, regular use of PDE5 inhibition to reduce the incidence of ED following penile nerve injury and to assuring normal function of the pelvic floor muscles. These approaches to maximizing erectile function are complementary rather than competitive, as they operate on entirely different aspects of erectile hydraulics.
    MeSH term(s) Age Factors ; Androgens/therapeutic use ; Animals ; Antioxidants/therapeutic use ; Arginine/therapeutic use ; Blood Vessels/metabolism ; Citrulline/therapeutic use ; Diet/adverse effects ; Erectile Dysfunction/etiology ; Erectile Dysfunction/physiopathology ; Erectile Dysfunction/therapy ; Exercise Therapy/methods ; Fatty Acids, Omega-3/therapeutic use ; Folic Acid/therapeutic use ; Humans ; Male ; Nitric Oxide/metabolism ; Obesity/complications ; Organ Sparing Treatments/adverse effects ; Pelvic Floor/physiology ; Penile Erection/physiology ; Penis/blood supply ; Penis/innervation ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Prostatectomy/adverse effects ; Regional Blood Flow/physiology ; Smoking/adverse effects ; Testosterone/therapeutic use ; Vasodilator Agents/therapeutic use
    Chemical Substances Androgens ; Antioxidants ; Fatty Acids, Omega-3 ; Phosphodiesterase 5 Inhibitors ; Vasodilator Agents ; Citrulline (29VT07BGDA) ; Nitric Oxide (31C4KY9ESH) ; Testosterone (3XMK78S47O) ; Folic Acid (935E97BOY8) ; Arginine (94ZLA3W45F)
    Language English
    Publishing date 2014-05
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2251959-2
    ISSN 1743-6109 ; 1743-6095
    ISSN (online) 1743-6109
    ISSN 1743-6095
    DOI 10.1111/jsm.12457
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins.

    Ignarro, L J

    Advances in pharmacology (San Diego, Calif.)

    1994  Volume 26, Page(s) 35–65

    Abstract: ... Ignarro, 1990). The studies on endothelium-derived relaxing factor and authentic NO have shown clearly ... of, these substances (Ignarro, 1989). The interaction between NO and the heme prosthetic group of guanylate cyclase ...

    Abstract The experimental evidence is convincing that cytosolic guanylate cyclase is a hemoprotein containing stoichiometric amounts of heme, which functions as a prosthetic group for enzyme activation by NO. Nearly all of the studies described in this chapter were conducted before we began to appreciate in 1986 that mammalian vascular endothelial cells could synthesize their own NO. We know now that many different cell types synthesize NO, and that in most instances the NO interacts in a paracrine manner with adjacent target cells to activate cytosolic guanylate cyclase and elevate intracellular levels of cyclic GMP (Ignarro, 1990). The studies on endothelium-derived relaxing factor and authentic NO have shown clearly that heme and hemoproteins have a very high binding affinity for, and inhibit the actions of, these substances (Ignarro, 1989). The interaction between NO and the heme prosthetic group of guanylate cyclase appears to constitute an important signal transduction mechanism whereby NO raises intracellular cyclic GMP levels. This novel signal transduction mechanism is highly conducive to the efficient functioning of NO as a paracrine mediator of cellular function. As a small, lipophilic, and chemically labile molecule, NO diffuses out of its cells of origin and into nearby target cells. The very high binding affinity of enzyme-bound heme for NO ensures interaction of the two to cause guanylate cyclase activation and cyclic GMP formation. Thus, relatively uncomplicated mechanism can account for the paracrine function of endogenous NO in transcellular communication.
    MeSH term(s) Animals ; Cytosol/enzymology ; Enzyme Activation/physiology ; Guanylate Cyclase/biosynthesis ; Guanylate Cyclase/metabolism ; Humans ; Metalloporphyrins/physiology ; Nitric Oxide/physiology ; Porphyrins/physiology ; Structure-Activity Relationship
    Chemical Substances Metalloporphyrins ; Porphyrins ; Nitric Oxide (31C4KY9ESH) ; Guanylate Cyclase (EC 4.6.1.2)
    Language English
    Publishing date 1994
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 1054-3589
    ISSN 1054-3589
    DOI 10.1016/s1054-3589(08)60050-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Nitric oxide-mediated vasorelaxation.

    Ignarro, L J

    Thrombosis and haemostasis

    1993  Volume 70, Issue 1, Page(s) 148–151

    MeSH term(s) Amino Acid Oxidoreductases/metabolism ; Humans ; Nitric Oxide/physiology ; Nitric Oxide Synthase ; Signal Transduction/physiology ; Vasodilation/drug effects ; Vasodilation/physiology
    Chemical Substances Nitric Oxide (31C4KY9ESH) ; Nitric Oxide Synthase (EC 1.14.13.39) ; Amino Acid Oxidoreductases (EC 1.4.-)
    Language English
    Publishing date 1993-07-01
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 518294-3
    ISSN 0340-6245
    ISSN 0340-6245
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Biological hydropersulfides and related polysulfides - a new concept and perspective in redox biology.

    Fukuto, Jon M / Ignarro, Louis J / Nagy, Peter / Wink, David A / Kevil, Christopher G / Feelisch, Martin / Cortese-Krott, Miriam M / Bianco, Christopher L / Kumagai, Yoshito / Hobbs, Adrian J / Lin, Joseph / Ida, Tomoaki / Akaike, Takaaki

    FEBS letters

    2018  Volume 592, Issue 12, Page(s) 2140–2152

    Abstract: The chemical biology of thiols (RSH, e.g., cysteine and cysteine-containing proteins/peptides) has been a topic of extreme interest for many decades due to their reported roles in protein structure/folding, redox signaling, metal ligation, cellular ... ...

    Abstract The chemical biology of thiols (RSH, e.g., cysteine and cysteine-containing proteins/peptides) has been a topic of extreme interest for many decades due to their reported roles in protein structure/folding, redox signaling, metal ligation, cellular protection, and enzymology. While many of the studies on thiol/sulfur biochemistry have focused on thiols, relatively ignored have been hydropersulfides (RSSH) and higher order polysulfur species (RSS
    MeSH term(s) Animals ; Cysteine/chemistry ; Humans ; Hydrogen Sulfide/chemistry ; Hydrogen Sulfide/metabolism ; Oxidation-Reduction ; Signal Transduction ; Sulfhydryl Compounds ; Sulfides/chemistry ; Sulfides/metabolism
    Chemical Substances Sulfhydryl Compounds ; Sulfides ; persulfides ; Cysteine (K848JZ4886) ; Hydrogen Sulfide (YY9FVM7NSN)
    Language English
    Publishing date 2018-05-24
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 212746-5
    ISSN 1873-3468 ; 0014-5793
    ISSN (online) 1873-3468
    ISSN 0014-5793
    DOI 10.1002/1873-3468.13090
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top